T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1376
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $11M | ﹤0.01% |
+379,463
| New | +$11M |
|
|
ELME
1377
Elme Communities
ELME
$1.51B
| $11M | ﹤0.01% |
498,853
-549,219
| -52% | -$12.1M |
|
|
MTEM
1378
DELISTED
Molecular Templates, Inc.
MTEM
| $10.7M | ﹤0.01% |
56,401
+54,375
| +2,684% | +$10.3M |
|
1379
Nektar Therapeutics
NKTR
$926M
| $10.6M | ﹤0.01% |
35,478
-1,115
| -3% | -$334K |
|
1380
Dell
DELL
$84.1B
| $10.6M | ﹤0.01% |
236,606
+43,256
| +22% | +$1.93M |
|
|
BHVN
1381
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.6M | ﹤0.01% |
154,547
-169
| -0.1% | -$11.6K |
|
|
DADA
1382
DELISTED
Dada Nexus
DADA
| $10.5M | ﹤0.01% |
386,741
-175,103
| -31% | -$4.75M |
|
1383
Invitation Homes
INVH
$18.5B
| $10.4M | ﹤0.01% |
325,445
+6,023
| +2% | +$193K |
|
1384
Leggett & Platt
LEG
$1.3B
| $10.4M | ﹤0.01% |
226,922
-9,198
| -4% | -$420K |
|
|
AUY
1385
DELISTED
Yamana Gold, Inc.
AUY
| $10.3M | ﹤0.01% |
2,381,562
+406,308
| +21% | +$1.77M |
|
1386
Hydrofarm Holdings
HYFM
$15.3M
| $10.3M | ﹤0.01% |
17,100
-18,090
| -51% | -$10.9M |
|
1387
Royal Gold
RGLD
$12.5B
| $10.2M | ﹤0.01% |
94,656
+16,596
| +21% | +$1.79M |
|
1388
Unum
UNM
$12.8B
| $10.2M | ﹤0.01% |
364,864
+2,896
| +0.8% | +$80.6K |
|
1389
Regenxbio
RGNX
$465M
| $10M | ﹤0.01% |
294,547
+5,711
| +2% | +$195K |
|
1390
Madrigal Pharmaceuticals
MDGL
$9.63B
| $10M | ﹤0.01% |
85,541
-85,668
| -50% | -$10M |
|
1391
Syndax Pharmaceuticals
SNDX
$1.34B
| $9.82M | ﹤0.01% |
439,017
+267,578
| +156% | +$5.98M |
|
|
ORTX
1392
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $9.8M | ﹤0.01% |
134,953
-131
| -0.1% | -$9.51K |
|
1393
EPR Properties
EPR
$4.45B
| $9.7M | ﹤0.01% |
208,115
+103,541
| +99% | +$4.82M |
|
1394
Disc Medicine
IRON
$2.08B
| $9.65M | ﹤0.01% |
+25,000
| New | +$9.65M |
|
1395
Fidelity National Financial
FNF
$16.4B
| $9.64M | ﹤0.01% |
246,499
-21,388
| -8% | -$836K |
|
|
RXDX
1396
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $9.59M | ﹤0.01% |
+525,000
| New | +$9.59M |
|
1397
Orchestra BioMed
OBIO
$139M
| $9.55M | ﹤0.01% |
850,000
| – | – |
|
|
GAP
1398
The Gap, Inc.
GAP
$8.5B
| $9.35M | ﹤0.01% |
313,973
-24,793
| -7% | -$738K |
|
|
AMK
1399
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $9.23M | ﹤0.01% |
395,472
+60,990
| +18% | +$1.42M |
|
1400
Urban Edge Properties
UE
$2.66B
| $9.18M | ﹤0.01% |
555,653
-229,656
| -29% | -$3.79M |
|